Skip to content

Pacemaker implant

DEVICE6 trials

Sponsors

Nanostim, Inc., Montreal Heart Institute, Castilla-La Mancha Health Service, Parc de Salut Mar, Institut d'Investigació Biomèdica de Bellvitge

Conditions

Aortic Valve StenosisAtrial Fibrillation With 2 or 3° AV or Bifascicular Bundle Branch (BBB) BlockAtrioventricular Block, Second and Third DegreeBradycardiaComplete Heart BlockComplicationDefibrillatorsHeart Failure

Unknown Phase

Evaluation of a New Cardiac Pacemaker
NCT01700244
Nanostim, Inc.Atrial Fibrillation With 2 or 3° AV or Bifascicular Bundle Branch (BBB) Block, Normal Sinus Rhythm With 2 or 3° AV or BBB Block, Sinus Bradycardia With Infrequent Pauses or Unexplained Syncope With EP Findings
Start: 2012-12-31End: 2013-08-31Target: 36Updated: 2013-06-26
Clinical Monitoring Strategy Versus Electrophysiology-guided Algorithmic Approach With a New LBBB After TAVI
RecruitingNCT03303612
Montreal Heart InstituteAortic Valve Stenosis, Left Bundle-Branch Block
Start: 2017-10-15End: 2026-12-31Target: 250Updated: 2025-05-08
Efficacy and Safety in Pacemaker and Defibrillator Implantation Via Cephalic Versus Axillary Vein Access (CEPHAX)
NCT03860090
Castilla-La Mancha Health ServiceComplication, Defibrillators, Pacemaker Electrode Lead Fracture +1
Start: 2017-10-01End: 2022-10-31Updated: 2019-03-01
Conduction System Stimulation to Avoid Left Ventricle Dysfunction
CompletedNCT06026683
Parc de Salut MarAtrioventricular Block, Second and Third Degree, Heart Failure, Pacemaker-Induced Cardiomyopathy
Start: 2019-09-30End: 2023-11-30Updated: 2024-04-03
Left Septal or Deep Septal Pacing to Prevent Pacing-induced Cardiomyopathy
RecruitingNCT06474819
Institut d'Investigació Biomèdica de BellvitgeComplete Heart Block, Second Degree Atrioventricular Block Möbitz Type II
Start: 2024-07-12End: 2027-01-12Target: 326Updated: 2024-07-15
Permanent Conduction System Pacing Versus Atrioventricular Management for Patients With Wide QRS and Patent AV Conduction
RecruitingNCT07585799
Óscar Cano PérezBradycardia
Start: 2025-07-29End: 2029-01-15Target: 120Updated: 2026-05-15

Related Papers